Operating profit before deduction of amortization: atarabio.com (ATRA)
Atara Biotherapeutics is implementing robotic bioreactors for precise cell cultivation, which, in synergy with partnerships with oncology centers, accelerates the fight against tumors. The trend in pre-tax operating profit captures this effect, where the 0.00 mark characterizes this parameter. Its first-mover status in allogeneic therapy in Europe will provide the company with sustainable margins and market dominance.
Atara Bio (ATRA) - metric breakdowns and financial figures
- stock value and consensus price forecast:
- company stock exchange capitalization indicators:
- shareholders' equity book value data:
- debt level and financial liquidity data:
Debt to Equity Ratio Atara Biotherapeutics|ATRA - Long-Term Debt to Capital|Current Liabilities to Capital Atara Biotherapeutics, Inc.|ATRA - Company Aggregate Debts|Debts to Book Capitalization Atara Biotherapeutics|ATRA - Company Long-Term Liabilities|Amount of Current Liabilities Atara Biotherapeutics|Quick Ratio atarabio.com
- earnings and multiples data:
ATRA - Company Net Income|Expected Net Income Atara Biotherapeutics|ATRA - P/E Multiple|Forward P/E Multiple Atara Biotherapeutics, Inc.|ATRA - Price/Earnings to Growth Multiple|Business Value to Operating Income Before Depreciation Atara Biotherapeutics|ATRA - Operating profit EBITDA|Earnings per share for the last twelve months Atara Biotherapeutics|ATRA - Net earnings per share (EPS TTM)|Year-over-year net earnings per share change for the last twelve months atarabio.com|ATRA - Earnings per share growth in current year|Expected net earnings per share growth next year Atara Biotherapeutics
Summary company analytics:ATRA (Atara Biotherapeutics)
Atara Biotherapeutics (ATRA) maintains resilience against market shocks through stable cash flow from European sales of its T-cell therapy and royalties, which offsets the risks of financial depletion. Monitoring operating profit in cash terms allows for the separation of one-off anomalies from systemic growth, helping investors avoid buying at peaks and minimizing correction risks when assessing the real efficiency of the business.
Competitor analysis for Atara Biotherapeutics
Operating income before deduction of amortization argenx BVBA (ARGX)|BNTX - Profit before payment of interest, taxes and amortization|Abivax S.A. (ABVX) - Operating profit before deduction of amortization|ADMA Biologics, Inc. (ADMA) - Profit before payment of interest, taxes and amortization|Operating profit before deduction of amortization Protagonist Therapeutics, Inc.|Operating profit before deduction of amortization IMVT|Operating profit EBITDA Kiniksa Corp|Profit before payment of interest, taxes and amortization Grifols, S.A. (GRFS)|adaptivebiotech.com - Operating profit before amortization|Operating profit EBITDA CLDX (Celldex Therapeutics, Inc.)|Aurinia Pharmaceuticals Inc (AUPH) - Profit before interest, taxes and amortization|BioCryst Pharmaceuticals Inc - Operating profit EBITDA|VERA - Operating profit EBITDA|DNTH (Dianthus Therapeutics) - Operating profit before deduction of amortization|PHVS: Company profit before taxes, interest and amortization|ABCL (AbCellera Biologics Inc.) - Operating profit EBITDA|Operating profit EBITDA Tourmaline Bio Inc|Profit before payment of interest, taxes and amortization Intrexon (PGEN)|PHAR (Pharming Corp) - Income before deduction of interest, taxes and amortization|Operating profit EBITDA NKTR (Nektar Therapeutics)|Operating profit EBITDA upstreambio.com UPB|ZBIO: Operating profit before deduction of amortization|Income before deduction of interest, taxes and amortization IMNM (Immunome Inc)|GOSS: Operating profit EBITDA|KALV (KalVista Corp) - Profit before payment of interest, taxes and amortization|SEPN (Septerna Inc) - Operating profit EBITDA|pieris.com (PVLA) - Operating income before deduction of amortization|Profit before payment of interest, taxes and amortization Savara (SVRA)|RIGL - Profit before interest, taxes and amortization|AnaptysBio Corp - Operating profit before deduction of amortization|Company profit before taxes, interest and amortization ATXS (Astria Corp)|enGene Holdings Inc. - Operating profit EBITDA|Income before deduction of interest, taxes and amortization RAPT (RAPT Therapeutics Inc.)|JBIO: Operating profit EBITDA|Profit before interest, taxes and amortization Aclaris Therapeutics Inc. (ACRS)|Profit before payment of interest, taxes and amortization Kyverna|TLSA: Income before deduction of interest, taxes and amortization|Operating profit EBITDA CABA|Operating profit EBITDA ventyxbio.com (VTYX)|Profit before payment of interest, taxes and amortization Theratechnologies THTX|AVTX (Avalo Therapeutics, Inc.) - Profit before deduction of interest, taxes, depreciation and amortization|Eledon - Operating profit EBITDA|Profit before interest, taxes and amortization Agenus, Inc|CLYM (Climb Bio Inc) - Operating profit before deduction of amortization|Zura Bio Ltd (ZURA) - Operating profit EBITDA|Operating profit before deduction of amortization ATYR|ADAG (Adagene Corp) - Company profit before taxes, interest and amortization|Operating profit EBITDA IMA|Operating income before deduction of amortization shattucklabs.com|Operating profit EBITDA EQ (Equillium)|CNTB - Operating profit before deduction of amortization|IMUX - Profit before payment of interest, taxes and amortization|Operating income before deduction of amortization InflaRx N.V. IFRX|XFOR: Operating profit EBITDA|Adicet Bio, Inc. (ACET) - Operating profit EBITDA|Operating profit before deduction of amortization CELU|INMB (inmunebio.com) - Company profit before taxes, interest and amortization|Profit before payment of interest, taxes and amortization Barinthus Biotherapeutics plc (BRNS)|KZR (Kezar Life Sciences Inc.) - Income before deduction of interest, taxes and amortization|Operating profit EBITDA SABS (SAB Biotherapeutics, Inc)|Operating profit EBITDA Akari Therapeutics, Plc AKTX|ENLV - Profit before payment of interest, taxes and amortization|Profit before deduction of interest, taxes, depreciation and amortization QTTB|GOVX: Operating profit EBITDA|Edesa Biotech Inc - Income before deduction of interest, taxes and amortization|IBIO (iBio Corp) - Operating profit EBITDA|Operating profit EBITDA Carisma Tx|Profit before payment of interest, taxes and amortization XTL Biopharmaceuticals (XTLB)|BOLT (boltbio.com) - Income before deduction of interest, taxes and amortization|Profit before payment of interest, taxes and amortization HCW Biologics HCWB|APVO - Operating profit before deduction of amortization|AIM ImmunoTech Inc. - Operating profit EBITDA|ADTX - Operating profit EBITDA|GRI (GRI Bio, Inc.) - Operating profit before deduction of amortization|xortx.com - Income before deduction of interest, taxes and amortization|HIND (Vyome Holdings) - Operating profit EBITDA|Revelation Biosciences Inc (REVB) - Operating income before deduction of amortization|Profit before payment of interest, taxes and amortization Indaptus (INDP)|Operating profit before deduction of amortization BiondVax Pharmaceuticals SCNI|Profit before payment of interest, taxes and amortization CalciMedica CALI|AFMD - Operating profit before deduction of amortization|ALLK: Operating profit before deduction of amortization|HOOK - Operating profit EBITDA|igmbio.com (IGMS) - Profit before payment of interest, taxes and amortization|Operating profit before amortization ITOS|OCEA (Ocean Biomedical, Inc.) - Operating profit EBITDA|Profit before interest, taxes and amortization tcbiopharm.com TCBP|Operating profit EBITDA THRD
